Alirocumab (anti-PCSK9), 1mg*25

Alirocumab (anti-PCSK9), 1mg*25

Necitumumab (anti-EGFR), 1mg*5

Necitumumab (anti-EGFR), 1mg*5

Necitumumab (anti-EGFR), 1mg

2.143,19 RON
SKU
SKM_A2048_1mg

Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.

Mai multe informatii
Price 1.801,00 RON (preturile sunt fara TVA)
Description

Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.